These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8989621)

  • 1. Development of the NMDA ion-channel blocker, aptiganel hydrochloride, as a neuroprotective agent for acute CNS injury.
    McBurney RN
    Int Rev Neurobiol; 1997; 40():173-95. PubMed ID: 8989621
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigational neuroprotective drugs in traumatic brain injury.
    Cawley MJ; Marburger RK; Earl GL
    J Neurosci Nurs; 1998 Dec; 30(6):369-74. PubMed ID: 9949976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of CNS 1102 in man.
    Muir KW; Grosset DG; Lees KR
    Ann N Y Acad Sci; 1995 Sep; 765():336-7. PubMed ID: 7486638
    [No Abstract]   [Full Text] [Related]  

  • 4. Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injury.
    Faden AI
    JAMA; 1984 Sep; 252(11):1452-4. PubMed ID: 6433052
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats.
    Gaviria M; Privat A; d'Arbigny P; Kamenka J; Haton H; Ohanna F
    Brain Res; 2000 Aug; 874(2):200-9. PubMed ID: 10960605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for spinal cord injury.
    Baptiste DC; Fehlings MG
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):63-80. PubMed ID: 18321149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological strategies in CNS trauma.
    Faden AI; Salzman S
    Trends Pharmacol Sci; 1992 Jan; 13(1):29-35. PubMed ID: 1311880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke.
    Dyker AG; Edwards KR; Fayad PB; Hormes JT; Lees KR
    Stroke; 1999 Oct; 30(10):2038-42. PubMed ID: 10512904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation.
    Tsai MJ; Liao JF; Lin DY; Huang MC; Liou DY; Yang HC; Lee HJ; Chen YT; Chi CW; Huang WC; Cheng H
    Neurochem Int; 2010 Dec; 57(8):867-75. PubMed ID: 20868716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
    Albers GW; Goldstein LB; Hall D; Lesko LM;
    JAMA; 2001 Dec; 286(21):2673-82. PubMed ID: 11730442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of aptiganel HCl (Cerestat) following controlled cortical impact injury in the rat.
    Kroppenstedt SN; Schneider GH; Thomale UW; Unterberg AW
    J Neurotrauma; 1998 Mar; 15(3):191-7. PubMed ID: 9528919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerestat and other NMDA antagonists in ischemic stroke.
    Lees KR
    Neurology; 1997 Nov; 49(5 Suppl 4):S66-9. PubMed ID: 9371155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacologic strategies for acute neuronal injury.
    Luer MS; Rhoney DH; Hughes M; Hatton J
    Pharmacotherapy; 1996; 16(5):830-48. PubMed ID: 8888078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical potential for the use of neuroprotective agents. A brief overview.
    Trembly B
    Ann N Y Acad Sci; 1995 Sep; 765():1-20; discussion 26-7. PubMed ID: 7486597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective pharmacology of methylprednisolone.
    Hall ED
    J Neurosurg; 1992 Jan; 76(1):13-22. PubMed ID: 1727150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in neuroprotection for treating traumatic brain injury.
    Cernak I
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1371-81. PubMed ID: 17040197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of melatonin in traumatic brain injury and spinal cord injury.
    Naseem M; Parvez S
    ScientificWorldJournal; 2014; 2014():586270. PubMed ID: 25587567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury.
    Maragos WF; Korde AS
    J Neurochem; 2004 Oct; 91(2):257-62. PubMed ID: 15447659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroids after spinal cord injury.
    Lancet; 1990 Aug; 336(8710):279-80. PubMed ID: 1973973
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury.
    Feldblum S; Arnaud S; Simon M; Rabin O; D'Arbigny P
    J Neurotrauma; 2000 Nov; 17(11):1079-93. PubMed ID: 11101210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.